Regeneration of coronary arterial system using biodegradable hydrogel combined with angiogenic growth factor
可生物降解水凝胶联合血管生成因子的冠状动脉系统再生
基本信息
- 批准号:16390393
- 负责人:
- 金额:$ 8.06万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This study was performed in an attempt to create a new arterial network which has connection with native coronary arteries by using biodegradable hydrogel fiber and angiogenic growth factor. In this experiment, hydrogel fiber was first treated with angiogenic growth factor and then was inserted into the myocardial fistula with a venous catheter. During absorption of the fiber, the luminal surface of the fistula became lined with endothelial cells. At the same time, released angiogenic growth factor was expected to enhance angiogenesis and arteriogenesis which are in communication with the newly developed myocardial fistula. For this purpose, several hydrogels and angiogenic factors were evaluated using mongrel dogs. Hyaluronic acid, which charged negatively, made ionic bond easily with positively charged basic fibroblast growth factor (b-FGF). In vivo, hyaluronic acid gel gradually released b-FGF and enhanced angiogenesis at 2 weeks without eliciting inflammatory responses. Chitosan, which charged positively, made stable bonding with platelet derived endothelial cell growth factor (PD-ECGF) gene. Although chitosan gel gradually released PD-ECGF gene which enhanced angiogenesis, it was not absorbed and caused potent inflammatory reaction in the surrounding tissue. Chitosan/polyvinyl alcohol gel provided the most promising results because it leads to the fistula formation as well as the enhanced angiogenesis with minimum inflammatory reaction at 2 weeks.
本研究尝试通过生物可降解水凝胶纤维和血管生成生长因子建立一个与自体冠状动脉连接的新动脉网络。在本实验中,首先用血管生成生长因子处理水凝胶纤维,然后用静脉导管插入心肌瘘中。在纤维吸收过程中,瘘管的管腔表面衬有内皮细胞。与此同时,释放的血管生成生长因子预计将增强血管生成和动脉生成,这与新发展的心肌瘘有关。为此,使用杂种狗评价了几种水凝胶和血管生成因子。带负电荷的透明质酸与带正电荷的碱性成纤维细胞生长因子(b-FGF)易形成离子键。在体内,透明质酸凝胶在2周时逐渐释放b-FGF并增强血管生成,而不引发炎症反应。带正电荷的壳聚糖与血小板源性内皮细胞生长因子(PD-ECGF)基因形成稳定结合。虽然壳聚糖凝胶逐渐释放PD-ECGF基因,促进血管生成,但它不能被吸收,并引起周围组织的强烈炎症反应。壳聚糖/聚乙烯醇凝胶提供了最有希望的结果,因为它导致瘘管形成以及增强的血管生成,在2周时具有最小的炎症反应。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs
- DOI:10.1152/ajpheart.00176.2004
- 发表时间:2005-01-01
- 期刊:
- 影响因子:4.8
- 作者:Li, W;Tanaka, K;Chiba, Y
- 通讯作者:Chiba, Y
Thymidine phosphorylase gene transfer inhibits vascular smooth muscle cell proliferation by upregulating heme oxygenase-1 and p27KIP1
- DOI:10.1161/01.atv.0000168914.85107.64
- 发表时间:2005-07-01
- 期刊:
- 影响因子:8.7
- 作者:Li, W;Tanaka, K;Ihaya, A
- 通讯作者:Ihaya, A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Kuniyoshi其他文献
TANAKA Kuniyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Kuniyoshi', 18)}}的其他基金
Study in Pharmacological Protection for Platelet Dysfunction during the Use of Blood contacting Artificial Organs
血液接触性人工器官使用过程中血小板功能障碍的药理保护研究
- 批准号:
11671314 - 财政年份:1999
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C).
相似海外基金
The impact of Hyaluronic Acid on growth factor signalling and angiogenesis
透明质酸对生长因子信号传导和血管生成的影响
- 批准号:
DP240101674 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Discovery Projects
Pre-clinical development of a live biotherapeutic product engineered to remodel hyaluronic acid in solid tumours to enable checkpoint inhibitor efficacy
一种活体生物治疗产品的临床前开发,旨在重塑实体瘤中的透明质酸,以实现检查点抑制剂的功效
- 批准号:
10078115 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Collaborative R&D
The role of hyaluronic acid and its receptors in the pathogenesis of endometriosis
透明质酸及其受体在子宫内膜异位症发病机制中的作用
- 批准号:
10894459 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Nitric oxide-releasing hyaluronic acid therapeutics for treating periodontal disease
释放一氧化氮的透明质酸疗法用于治疗牙周病
- 批准号:
10657158 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Development of postoperative prevention of peritoneal metastasis by inhibition of hyaluronic acid-CD44 axis of intraperitoneal gastric cancer cells during surgery
术中抑制腹腔内胃癌细胞透明质酸-CD44轴预防术后腹膜转移的研究进展
- 批准号:
23K14564 - 财政年份:2023
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Sustainable synthesis of Hyaluronic Acid via engineered strains of non-pathogenic bacteria - from carbon dioxide and waste feedstock to low-cost, sustainable, and waste-free Hyaluronic Acid for cosmetics, medicine, and nutraceuticals
通过非致病性细菌的工程菌株可持续合成透明质酸 - 从二氧化碳和废弃原料到用于化妆品、药品和营养品的低成本、可持续且无废物的透明质酸
- 批准号:
10034038 - 财政年份:2022
- 资助金额:
$ 8.06万 - 项目类别:
Collaborative R&D
Local modulation of S1P receptor signaling with nanofibrous hyaluronic acid scaffolds as a regenerative immunotherapy following critical volumetric muscle loss injury
使用纳米纤维透明质酸支架局部调节 S1P 受体信号作为关键体积肌肉损失损伤后的再生免疫疗法
- 批准号:
10390016 - 财政年份:2022
- 资助金额:
$ 8.06万 - 项目类别:
Local modulation of S1P receptor signaling with nanofibrous hyaluronic acid scaffolds as a regenerative immunotherapy following critical volumetric muscle loss injury
使用纳米纤维透明质酸支架局部调节 S1P 受体信号作为关键体积肌肉损失损伤后的再生免疫疗法
- 批准号:
10591401 - 财政年份:2022
- 资助金额:
$ 8.06万 - 项目类别:
Analysis of the function of hyaluronic acid in vascular endothelial glycocalyx
透明质酸在血管内皮糖萼中的功能分析
- 批准号:
22K09179 - 财政年份:2022
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ERI:Network by network fabrication approach of bioinspired scaffolds to study the effect of fibrin and hyaluronic acid on the reactive and inflammatory response of human astrocytes
ERI:网络通过仿生支架的网络制造方法研究纤维蛋白和透明质酸对人星形胶质细胞反应和炎症反应的影响
- 批准号:
2138684 - 财政年份:2022
- 资助金额:
$ 8.06万 - 项目类别:
Standard Grant